Literature DB >> 14997939

The genetic spectrum of human neuronal ceroid-lipofuscinoses.

Sara E Mole1.   

Abstract

The neuronal ceroid lipofuscinoses (NCL), also known as Batten disease, are a group of inherited severe neurodegenerative disorders primarily affecting children. They are characterised by the accumulation of autofluorescent storage material in many cells. Children suffer from visual failure, seizures, progressive physical and mental decline and premature death, associated with the loss of cortical neurones. Six genes have been identified that cause human NCL (CLN1, CLN2, CLN3, CLN5, CLN6, CLN8), and approximately 150 mutations have been described. The majority of mutations result in a characteristic disease course for each gene. However, mutations associated with later disease onset or a more protracted disease course have also been described. At least seven common mutations exist, either with a world-wide distribution or associated with families from specific countries. All mutations are described in the NCL Mutation Database (http://www.uc.ac.uk/ncl).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997939     DOI: 10.1111/j.1750-3639.2004.tb00500.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  28 in total

1.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

2.  Batten disease: features to facilitate early diagnosis.

Authors:  J Collins; G E Holder; H Herbert; G G W Adams
Journal:  Br J Ophthalmol       Date:  2006-06-05       Impact factor: 4.638

Review 3.  Cathepsin deficiency as a model for neuronal ceroid lipofuscinoses.

Authors:  John J Shacka; Kevin A Roth
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 4.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

5.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

6.  A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis.

Authors:  E Stogmann; S El Tawil; J Wagenstaller; A Gaber; S Edris; A Abdelhady; E Assem-Hilger; F Leutmezer; S Bonelli; C Baumgartner; F Zimprich; T M Strom; A Zimprich
Journal:  Neurogenetics       Date:  2008-10-11       Impact factor: 2.660

7.  The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis.

Authors:  Jake N Miller; Chun-Hung Chan; David A Pearce
Journal:  Hum Mol Genet       Date:  2013-03-28       Impact factor: 6.150

8.  JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence.

Authors:  Taina H Autti; Janne Hämäläinen; Minna Mannerkoski; Koen Van Van Leemput; Laura E Aberg
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

9.  Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Authors:  Chun-Hung Chan; Hannah M Mitchison; David A Pearce
Journal:  Hum Mol Genet       Date:  2008-08-04       Impact factor: 6.150

10.  A critical tryptophan and Ca2+ in activation and catalysis of TPPI, the enzyme deficient in classic late-infantile neuronal ceroid lipofuscinosis.

Authors:  Salomon Kuizon; Kathleen DiMaiuta; Marius Walus; Edmund C Jenkins; Marisol Kuizon; Elizabeth Kida; Adam A Golabek; Daniel O Espinoza; Raju K Pullarkat; Mohammed A Junaid
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.